Financials

  • Market Capitalization 1.86 B
  • Employee 161
  • Founded 2019
  • CEO N/A
  • Website www.monterosatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00X2VGZQ3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-33.72
市销率
10.53

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2014
URGN
UroGen Pharma Ltd. - Ordinary Shares
39.51 USD+2.46%+5.36%+33.71%+107.95%1.92 B USD
2028
NBTX
Nanobiotix S.A. - ADSs
39.15 USD-2.30%-3.69%+5.24%+629.05%1.90 B USD
2044
BCAX
Bicara Therapeutics Inc. - Common Stock
28.15 USD-2.63%-4.41%+28.36%+94.94%1.85 B USD
2051
PGEN
Precigen, Inc. - Common Stock
5.17 USD-2.82%-8.17%+12.39%+163.78%1.84 B USD

新闻